SEC Form 4 research
| Issuer | Keros Therapeutics, Inc. |
|---|---|
| Tickers | KROS |
| Reporting owners | 37 |
| Officers and directors | 17 |
| Last public filing | 2026-08-21 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-20 | 2026-08-18 | Tanini Annita | S | 1,224 | $10.29 | Not reported |
| 2026-08-20 | 2026-08-18 | Cho Esther | S | 4,485 | $10.29 | Not reported |
| 2026-08-20 | 2026-08-18 | Lerner Lorena Raquel | S | 3,568 | $10.29 | Not reported |
| 2026-08-20 | 2026-08-18 | Newton Charles W. | S | 551 | $10.3 | Not reported |
| 2026-08-19 | 2026-08-17 | BIENAIME JEAN JACQUES | P | 1,000 | $10.27 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.